))
303. Long-Term Therapies in NMOSD
Manage episode 332247383 series 3240321
Content provided by Siegel Rare Neuroimmune Association (SRNA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Siegel Rare Neuroimmune Association (SRNA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
For this “ABCs of NMOSD” podcast titled "Long-Term Therapies in NMOSD," SRNA's Dr. GG deFiebre was joined by Dr. Dean M. Wingerchuk. Dr. Wingerchuk began by explaining the difference between acute versus long-term treatments and providing an overview of the most common long-term treatments for NMOSD. He then discussed side effects and effectiveness. Finally, Dr. Wingerchuk provided information on factors to consider when someone is considering which long-term treatment to use, including antibody testing, approval from medical insurance, and relapse occurrence.
30 episodes
Share
